Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial.

Andrea Casadei GardiniEmanuela ScarpiMartina ValgiustiManlio MontiSilvia RuscelliLaura MatteucciGiulia BartoliniBernadette VertogenFlavia PaganGiulia RovestiGiovanni Luca FrassinetiAlessandro Passardi

Published in: Therapeutic advances in medical oncology (2020)

ClinicalTrials.gov identifier: NCT01878422 (registration date: 07/06/2013) https://clinicaltrials.gov/ct2/show/NCT01878422.

Keyphrases

metastatic colorectal cancer
phase iii
phase ii
open label
double blind
clinical trial
placebo controlled
computed tomography
study protocol
image quality
oxidative stress
contrast enhanced
dual energy
randomized controlled trial
positron emission tomography